Hello,

Hello,

Hello everyone,

Was wondering how your institutions build multicomponent mixtures in your smartpumps. We have been working very diligently to improve our DERS compliance with our pumps. In working towards that 95% compliance goal, we continue to try to come up with the best way to have entries for our multicomponent mixtures. The especially challenging part is establishing the min/max parameters. Do you set those just based on one component?

Good afternoon,
We've encountered safety issues with incorrect dosing/monitoring of vancomycin and aminoglycosides in peritoneal dialysis solutions, and are exploring options to improve the safety of our process. For example, a patient receiving vancomycin daily versus intermittently based on levels. Unfamiliarity with PD dosing and infrequent use are contributing factors we've identified. How does your institution handle these orders safely to ensure accurate dosing/monitoring?
- Do you incorporate pharmacy consults? How is that operationalized?

Hi,

ISMP has repeatedly suggested that sites take action to prevent PCA by proxy. In 2016, a "Worth Repeating" article suggested "Assess the need for warning signage
Assess whether warning signs are necessary on PCA cords to alert family members and remind staff that PCA doses should be administered only by patients. If used, be sure the warning is clear and understandable to patients, family members, and staff (e.g., WARNING: BUTTON TO BE PRESSED ONLY BY THE PATIENT)."

Good afternoon,
We've encountered safety issues with incorrect dosing/monitoring of vancomycin and aminoglycosides in peritoneal dialysis solutions, and are exploring options to improve the safety of our process. For example, a patient receiving vancomycin daily versus intermittently based on levels. Unfamiliarity with PD dosing and infrequent use are contributing factors we've identified. How does your institution handle these orders safely to ensure accurate dosing/monitoring?
- Do you incorporate pharmacy consults? How is that operationalized?

We are working on updating our Lipid Rescue kits(used for local anesthetic toxicity) in the Pyxis machines. I am specifically looking for information on whether the use of the 1.2 micron filter tubing is necessary in this situation. Also, if the filter tubing even supports the high rates of infusion(question has been posed to the manufacturer, but no reply yet). Rates of infusion can be more than the Alaris pump max rates of 999ml/hr. Any info and/or suggestions is appreciated!

Can anyone share if you have specific medications, infusion rates, or patient populations that you use microbore tubing over standard macrobore tubing for medication infusions?

If you made a change from macrobore to microbore for any particular medications, were there any safety concerns or events that led to that change?

Thanks in advance!
Dana

We have inconsistencies in dispensing (mostly IV) medications in light-protected bags in accordance to Lexicomp instructions for "Protect from Light." There are some medications that Lexicomp recommends to "Protect from Light" under storage conditions only, and some also includes it under administration. Do you dispense medications in light-protected bags if the recommendation is only mentioned under storage conditions or only if also mentioned under administration? Thank you. -Melody Sun, CHOC Children's

One of our pharmacists found an article regarding daptomycin stability that states that once reconstituted and injected into infusion bags, they can be stored for up to 7 days when stored at 2-8 degrees Celsius ("Stability of daptomycin reconstituted